Vietnam Inhaled Nitric Oxide Market Analysis

Vietnam Inhaled Nitric Oxide Market Analysis


$ 3999

Vietnam inhaled nitric oxide market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors driving the growth of this market are the rising prevalence of respiratory and other associated diseases and ongoing research and development activities. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.

ID: IN10VNPH314 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Riddhi Solanki

Buy Now

Vietnam Inhaled Nitric Oxide Market Analysis Summary

Vietnam Inhaled Nitric Oxide Market is valued at around $4.6 Mn in 2022 and is projected to reach $8.2 Mn by 2030, exhibiting a CAGR of 7.51% during the forecast period 2023-2030.

Nitric oxide (iNO), which is inhaled, is a colourless and odourless gas that is soluble in water. It is a pulmonary vasodilator that is crucial for the activation of guanylyl cyclase, which results in the production of cyclic guanosine monophosphate and subsequent smooth muscle relaxation. Additionally, nitric oxide inhalation has therapeutic advantages and is used to treat a number of disorders with a respiratory component. Additionally, the medicine is excellent for treating some premature patients with acute respiratory distress syndrome or premature lung disease. Nitric oxide inhaled is used to treat COPD (chronic obstructive pulmonary disease), malaria, TB, and the respiratory system of newborns.

Numerous industries are experiencing an increase in demand for inhaled nitric oxide, which is fueling the market's quick growth. To treat respiratory failure in preterm babies, the medication is used in conjunction with a breathing apparatus or ventilator. Additionally, the drug helps to relax smooth muscle, which can enlarge and expand blood vessels, particularly in the lungs. Nitric oxide inhalation may rise as a result of factors like the booming healthcare sector, rising rates of respiratory conditions like asthma and chronic obstructive pulmonary disease, and an ageing population with deteriorating lung function. As a result, this will encourage market expansion. The key players in this market are Mallinckrodt, Linde plc., Air Liquide, BOC Limited, Bellerophon Therapeutics, Beyond Air Inc., Halma plc, VERO Biotech, Nu-Med Plus, Getinge AB, Merck KGaA, Genosys Informatics, Geno, and Perma Pure LLC.

Market Dynamics

Market Growth Drivers

The global rise in acute respiratory distress syndrome (ARDS) is one of the main factors propelling the inhaled nitric oxide market's expansion. If research and development expenditures increased with the goal of enhancing the use of inhaled nitric oxide in the healthcare industry, the demand for inhaled nitric oxide would undoubtedly rise. The increased need for medications to treat hypoxemic respiratory failure in newborn infants is benefiting the industry. In infants with persistent pulmonary hypertension, it is highly effective at increasing oxygenation (PPHN). Due to its targeted pulmonary vasodilator effects, INO therapy is largely used to treat newborns with hypoxemic respiratory failure.

Market Restraints

However, the market for inhaled nitric oxide is being restricted by strict rules that are being implemented by governments in different countries governing the product use. Moreover the high cost associated with the use of inhaled nitric oxide will hamper the market growth.

Competitive Landscape

Key Players

  • Mallinckrodt
  • Linde Plc.
  • Air Liquide
  • BOC Limited
  • Bellerophon Therapeutics
  • Beyond Air Inc.
  • Halma Plc
  • VERO Biotech
  • Nu-Med Plus
  • Getinge AB
  • Merck KGaA
  • Genosys Informatics
  • Geno
  • Perma Pure LLC.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Inhaled Nitric Oxide Market Segmentation

By Strength

  • 100 ppm
  • 800 ppm
  • Others

By Purity

  • 99.92% Purity
  • 99.99% Purity
  • Others

By Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Neonatal Respiratory Treatment
  • Tuberculosis Treatment
  • Acute Respiratory Distress Syndrome (ARDS)
  • Malaria Treatment
  • Others

By End Users

  • Hospitals
  • Specialty Clinics
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up